What is LOPJLB’s current signal on AYTU?

LOPJLB’s latest quantitative signal on Aytu BioPharma, Inc. (AYTU) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is AYTU in?

Aytu BioPharma, Inc. (AYTU) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Aytu BioPharma, Inc. (AYTU) do?

Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international markets. Its commercialized portfolio includes several treatments for Attention Deficit Hyperactivity Disorder (ADHD): Adzenys XR-ODT, prescribed for patients aged 6 and up; Cotempla XR-ODT, tailore…

Where is Aytu BioPharma, Inc. based / listed?

Aytu BioPharma, Inc. is based in US, listed on NASDAQ.

Aytu BioPharma, Inc. (AYTU) Stock · BUY · RECOVERY

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $19M
Avg volume: 34.8K
Beta: 0.26
P/E (TTM): -0.54

Short % float: 4.29%
Days to cover: 12.5
SI change: -6.0%

1W: -2.12%
1M: +6.94%
3M: +5.48%
YTD: -16.61%

vs SPY 1W: -0.93%
vs SPY 1M: +3.62%
vs SPY 3M: +3.09%
vs SPY YTD: -28.36%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

ANLBUYAdlai Nortye Ltd.$752MRECOVERYQ 14$14.16+3.36%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Aytu BioPharma, Inc. (AYTU)

Key stats

Sector peers

Industry peers

Prediction markets

ANALYST & RATINGS

Company news